( January 28, 2026, 1:30 PM EST) -- WASHINGTON, D.C. — The U.S. Patent Trial and Appeal Board (PTAB) erroneously required a health care company to provide proof for the motivation to combine prior art references “because the prior art reference expressly discloses performing those steps in sequence,” a Federal Circuit U.S. Court of Appeals panel ruled....